A share price of Alto Neuroscience Inc. [ANRO] is currently trading at $11.65, up 4.95%. An important factor to consider is whether the stock is rising or falling in short-term value. The ANRO shares have gain 16.97% over the last week, with a monthly amount glided 5.91%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On February 27, 2024, Stifel initiated with a Buy rating and assigned a price target of $32 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $32 on February 27, 2024. Jefferies initiated its recommendation with a Buy and recommended $33 as its price target on February 27, 2024.
Alto Neuroscience Inc. experienced fluctuations in its stock price throughout the past year between $9.40 and $24.00. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Alto Neuroscience Inc. [NYSE: ANRO] shares were valued at $11.65 at the most recent close of the market. An investor can expect a potential return of 174.68% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.14 points at the first support level, and at 10.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.89, and for the 2nd resistance point, it is at 12.17.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Alto Neuroscience Inc. [NYSE:ANRO] is 26.02. On the other hand, the Quick Ratio is 26.02.
Transactions by insiders
Recent insider trading involved Smith Nicholas Conrad, CHIEF FINANCIAL OFFICER, that happened on Mar 28 ’24 when 6150.0 shares were purchased. 10% Owner, Alpha Wave Global, LP completed a deal on Feb 06 ’24 to buy 0.6 million shares. Meanwhile, CHIEF MEDICAL OFFICER Savitz Adam bought 17000.0 shares on Feb 06 ’24.
